Navigation Links
Grifols Starts Construction of a New Plasma Fractionation Plant in Barcelona (Parets Del Valles)
Date:2/18/2011

BARCELONA, Spain, Feb. 18, 2011 /PRNewswire/ -- Grifols, the Spanish group which specializes in the hospital-pharmaceutical sector and is one of the world's leading producers of plasma products, will shortly start construction of a new plant representing an investment of 20 million euros that will employ about 100 people, as soon as it obtains local permits and licenses. The new facilities will have the capacity to fractionate 1 million liters of plasma a year (with potential to expand to 2 million), allowing the group to double its existing fractionation capacity in Spain. The Grifols plant in Los Angeles, California, currently has a capacity of 2.2 million liters, giving the group total capacity of 6.3 million liters in 2014.

The construction work is scheduled to take 18 months, after which the process of obtaining licenses from the FDA (Food & Drug Administration) in the United States and from the EMA (European Medicines Agency) will begin. This is expected to take no more than two years, as the new plant will fractionate plasma through to the intermediate product stage. The purification, inactivation and sterile filling stages for the different proteins will be performed at Grifols' existing facilities at Parets del Valles, which have already been adapted to absorb this increased level of production.

The new plant will use the very latest technology and will make maximum use of automation. Grifols Engineering S.A., a group company which specializes in the engineering of biotechnological and pharmaceutical processes, has designed the new facilities and will manage the construction project. The plant will also serve as a model for the future construction of another fractionation plant in the United States (San Marcos, Texas) due to start in 2014, and delivering a maximum capacity of 4 million liters.

The new plant forms part of the 433 million euro investment plan for the period 2008-2012, approved at the end of 2007 by the Board of
'/>"/>

SOURCE Grifols
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Health Robotics CytoCare(TM) Global Expansion Continues With Grifols International in Latin America
2. AMDL Diagnostics, Inc. Enters Into Exclusive Distribution Agreement With Grifols USA, LLC to Advance Commercialization of DR-70 Onko-Sure(TM) Cancer Test
3. Grifols Agrees to Acquire Intellectual Property for Treatment of Post-Polio Syndrome From Pharmalink AB
4. Health Robotics CytoCare Continues European Expansion With Grifols and Vall dHebron University Hospital
5. NASDAQ Removes TLCR From Biotechnology Index Pending FTC Decision on Grifols Acquisition
6. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
7. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
8. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
9. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
10. U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)
11. Presbyterian Hospital Dallas Starts Advanced Breast-Cancer Risk-Assessment Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements ... announced tender offer by its indirect wholly-owned subsidiary, Sapphire ... of common stock of Solta Medical, Inc. (NASDAQ: ... per share, net to the seller in cash, without ...
(Date:1/15/2014)... Jan. 15, 2014  Zafgen, Inc., a leading ... of severely obese patients, today announced initial results ... selective inhibitor of methionine aminopeptidase 2 (MetAP2), in ... of genetic obesity.  These results showed improvements in ... reductions in body fat content and preserved lean ...
(Date:1/14/2014)... , Jan. 14, 2014  Luminex Corporation (Nasdaq: ... report results for the fourth quarter of 2013 on ... results is scheduled for release after the close of ... Management will hold a conference call to discuss ... quarter and twelve months ended December 31, 2013 on ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3
... CUPERTINO, Calif. , July 1 DURECT Corporation (Nasdaq: DRRX ... which it may sell up to $50 million of its registered ... is not obligated to utilize any of the $50 million facility. ... this facility. , , , ...
... /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd.,(Nasdaq: DHRM ), an emerging ... medical products in China , said today,that Rita Zheng Liu ... will present at the Global Hunter,Securities 2010 China Conference to be held ... , , ...
Cached Medicine Technology:DURECT Corporation Secures $50 Million Committed Equity Financing Facility 2DURECT Corporation Secures $50 Million Committed Equity Financing Facility 3Dehaier Medical Systems to Present to Investors at Global Hunter Securities 2010 China Investor Conference in San Francisco 2Dehaier Medical Systems to Present to Investors at Global Hunter Securities 2010 China Investor Conference in San Francisco 3
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... similar medicines pose big stomach risks, study notes ... of patients don,t tell their doctors that they take ... potentially dangerous omission, a new study has found. , ... medicine intake, it is no wonder that adverse events ...
... four out of ten HIV positive African-American men could be putting ... in the latest UK-based Journal of Advanced Nursing. , A ... that many of the 40 to 65 year-olds were engaging in ... oral sex, with 25 per cent having unprotected vaginal sex and ...
... contribute to heart attack, stroke and dementia, likely also ... researchers say. , Homocysteine levels rise when folic acid ... are often poor in folate-rich fruits, tomatoes, vegetables and ... the Medical College of Georgia. , Scientists want to ...
... Donates Hotel Points to Benefit More Transplant Patients and Family ... ... The National Foundation for,Transplants (NFT) announced today that it will extend free ... to,pre- and post-transplant care through an expansion of its Home Away From,Home ...
... Winners Announced at Annual ASRM Meeting, ... won Ferring,Pharmaceuticals, national 2007 My Little Miracle ... the births of their ,little miracles,children born ... fertility treatments.,The fourth annual contest celebrated the ...
... Oct. 15 Edwards Lifesciences,Corporation (NYSE: EW ), ... cardiovascular disease, plans to announce its operating,results for the ... on,Monday, October 22, 2007 and will host a conference ... results. To participate in the conference call, dial ...
Cached Medicine News:Health News:Many Patients Don't Report Use of OTC Pain Drugs 2Health News:Many Patients Don't Report Use of OTC Pain Drugs 3Health News:Older African-American men with HIV often have sex without condoms 2Health News:Impact of elevated homocysteine levels on vision under study 2Health News:Impact of elevated homocysteine levels on vision under study 3Health News:National Foundation for Transplants to Expand Program Providing Hotel Accommodations to Patient Families 2Health News:National Foundation for Transplants to Expand Program Providing Hotel Accommodations to Patient Families 3Health News:Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest 2Health News:Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest 3Health News:Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest 4Health News:Edwards Lifesciences to Host Earnings Conference Call on October 22, 2007 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: